Publication | Closed Access
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
36
Citations
30
References
2020
Year
Neuro-oncologyRadiation MedicineRadiation TherapyMedicinePharmacologyConcomitant TemozolomideHigh-grade GliomasCancer TreatmentRadiation OncologyOncologyGliomaPhase 1
| Year | Citations | |
|---|---|---|
Page 1
Page 1